| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |